M Musumeci1,2, A Palermo3, L D'Onofrio4, G Vadalà2, V Greto4, E Di Stasio5, E Maddaloni4, M Di Rosa6, D Tibullo7, S Angeletti, A Silvia1, N Napoli4, V Denaro2, S Manfrini4. 1. Clinical Pathology and Microbiology Laboratory, University Campus Bio-Medico, Rome, Italy. 2. Department of Orthopaedic surgery, University Campus Bio-Medico, Rome, Italy. 3. Department of Endocrinology and Diabetes, University Campus Bio-Medico, Via Alvaro del Portillo, 21 - 00128, Rome, Italy. a.palermo@unicampus.it. 4. Department of Endocrinology and Diabetes, University Campus Bio-Medico, Via Alvaro del Portillo, 21 - 00128, Rome, Italy. 5. Institute of Biochemistry and clinical Biochemistry, University Cattolica del Sacro Cuore, Rome, Italy. 6. Department of Bio-medical Sciences, University of Catania, Catania, Italy. 7. Department of Clinical and Molecular Biomedicine, University of Catania, Ospedale Ferrarotto, Catania, Italy.
Abstract
UNLABELLED: Human chitotriosidase (Chit) increases during the osteoclast differentiation and their activity. We demonstrated that serum Chit was significantly higher in osteoporotic subjects than in healthy control ones and revealed a negative correlation between Chit and bone mineral density (BMD). This is the first study showing a correlation between Chit and severe postmenopausal osteoporosis. INTRODUCTION: Mammalian chitinases exert important biological roles in the monocyte lineage and chronic inflammatory diseases. In particular, Chit seems to promote bone resorption in vitro. No in vivo studies have been performed to confirm this finding. We aim to evaluate Chit activity in postmenopausal women affected by severe osteoporosis. METHODS: In this cross-sectional study, 91 postmenopausal women affected by osteoporosis and 61 with either osteopenia or normal BMD were screened. All subjects were assessed by dual-energy X-ray absorptiometry (DXA) and X-ray vertebral morphometry. Osteoporotic subjects were considered eligible if they were affected by at least one vertebral osteoporotic fracture (group A = 57 subjects). Osteopenic or healthy subjects were free from osteoporotic fractures (group B = 51 subjects). Enzymatic Chit and serum β-CrossLaps (CTX) were measured in the whole population. RESULTS: Group A showed higher serum levels of beta-CTX compared to group B (0.40 ± 0.26 ng/mL vs 0.29 ± 0.2 ng/mL, p = 0.022). Chit was significantly higher in group A than in group B (1042 ± 613 nmol/mL/h vs 472 ± 313 nmol/mL/h, p < 0.001, respectively) even after adjustment for age (p < 0.001). Spearman correlation test revealed a negative correlation between Chit and BMD at each site (lumbar spine: r = -0.38, p = 0.001, femoral neck: r = -0.35, p = 0.001, total femur: r = -0.39, p < 0.001). Furthermore, a positive correlation between Chit and PTH was observed (r = 0.26, p = 0.013). No significant correlation was found between Chit and beta-CTX (r = 0.12, p = 0.229). After a multivariate analysis, a positive correlation between severe osteoporosis and Chit (p < 0.001), beta-CTX (p = 0.013), and age (p < 0.001) was observed. CONCLUSION: This is the first clinical study showing a correlation between Chit and severe postmenopausal osteoporosis. Larger and prospective studies are needed to evaluate if Chit may be a promising clinical biomarker and/or therapeutic monitor in subjects with osteoporosis.
UNLABELLED: Humanchitotriosidase (Chit) increases during the osteoclast differentiation and their activity. We demonstrated that serum Chit was significantly higher in osteoporotic subjects than in healthy control ones and revealed a negative correlation between Chit and bone mineral density (BMD). This is the first study showing a correlation between Chit and severe postmenopausal osteoporosis. INTRODUCTION:Mammalian chitinases exert important biological roles in the monocyte lineage and chronic inflammatory diseases. In particular, Chit seems to promote bone resorption in vitro. No in vivo studies have been performed to confirm this finding. We aim to evaluate Chit activity in postmenopausal women affected by severe osteoporosis. METHODS: In this cross-sectional study, 91 postmenopausal women affected by osteoporosis and 61 with either osteopenia or normal BMD were screened. All subjects were assessed by dual-energy X-ray absorptiometry (DXA) and X-ray vertebral morphometry. Osteoporotic subjects were considered eligible if they were affected by at least one vertebral osteoporotic fracture (group A = 57 subjects). Osteopenic or healthy subjects were free from osteoporotic fractures (group B = 51 subjects). Enzymatic Chit and serum β-CrossLaps (CTX) were measured in the whole population. RESULTS: Group A showed higher serum levels of beta-CTX compared to group B (0.40 ± 0.26 ng/mL vs 0.29 ± 0.2 ng/mL, p = 0.022). Chit was significantly higher in group A than in group B (1042 ± 613 nmol/mL/h vs 472 ± 313 nmol/mL/h, p < 0.001, respectively) even after adjustment for age (p < 0.001). Spearman correlation test revealed a negative correlation between Chit and BMD at each site (lumbar spine: r = -0.38, p = 0.001, femoral neck: r = -0.35, p = 0.001, total femur: r = -0.39, p < 0.001). Furthermore, a positive correlation between Chit and PTH was observed (r = 0.26, p = 0.013). No significant correlation was found between Chit and beta-CTX (r = 0.12, p = 0.229). After a multivariate analysis, a positive correlation between severe osteoporosis and Chit (p < 0.001), beta-CTX (p = 0.013), and age (p < 0.001) was observed. CONCLUSION: This is the first clinical study showing a correlation between Chit and severe postmenopausal osteoporosis. Larger and prospective studies are needed to evaluate if Chit may be a promising clinical biomarker and/or therapeutic monitor in subjects with osteoporosis.
Authors: Markus Ries; Ellen Schaefer; Till Lührs; Latha Mani; Jana Kuhn; Marie T Vanier; Frank Krummenauer; Andreas Gal; Michael Beck; Eugen Mengel Journal: J Inherit Metab Dis Date: 2006-07-27 Impact factor: 4.982
Authors: Sun Wook Cho; Fabiana N Soki; Amy J Koh; Matthew R Eber; Payam Entezami; Serk In Park; Nico van Rooijen; Laurie K McCauley Journal: Proc Natl Acad Sci U S A Date: 2014-01-09 Impact factor: 11.205
Authors: D L Lacey; E Timms; H L Tan; M J Kelley; C R Dunstan; T Burgess; R Elliott; A Colombero; G Elliott; S Scully; H Hsu; J Sullivan; N Hawkins; E Davy; C Capparelli; A Eli; Y X Qian; S Kaufman; I Sarosi; V Shalhoub; G Senaldi; J Guo; J Delaney; W J Boyle Journal: Cell Date: 1998-04-17 Impact factor: 41.582
Authors: Marco van Eijk; Cindy P A A van Roomen; G Herma Renkema; Anton P Bussink; Laura Andrews; Edward F C Blommaart; Alan Sugar; Arthur J Verhoeven; Rolf G Boot; Johannes M F G Aerts Journal: Int Immunol Date: 2005-10-07 Impact factor: 4.823
Authors: R G Boot; E F Blommaart; E Swart; K Ghauharali-van der Vlugt; N Bijl; C Moe; A Place; J M Aerts Journal: J Biol Chem Date: 2000-11-20 Impact factor: 5.157
Authors: Linda Vi; Gurpreet S Baht; Heather Whetstone; Adeline Ng; Qingxia Wei; Raymond Poon; Sivakami Mylvaganam; Marc Grynpas; Benjamin A Alman Journal: J Bone Miner Res Date: 2015-06 Impact factor: 6.741
Authors: Paul J Orchard; Troy Lund; Wes Miller; Steven M Rothman; Gerald Raymond; David Nascene; Lisa Basso; James Cloyd; Jakub Tolar Journal: J Neuroinflammation Date: 2011-10-20 Impact factor: 8.322
Authors: Mohamed A Elmonem; Samuel H Makar; Lambertus van den Heuvel; Hanan Abdelaziz; Safaa M Abdelrahman; Xavier Bossuyt; Mirian C Janssen; Elisabeth Am Cornelissen; Dirk J Lefeber; Leo Ab Joosten; Marwa M Nabhan; Fanny O Arcolino; Fayza A Hassan; Héloïse P Gaide Chevronnay; Neveen A Soliman; Elena Levtchenko Journal: Orphanet J Rare Dis Date: 2014-11-19 Impact factor: 4.123
Authors: David Bennett; Paolo Cameli; Nicola Lanzarone; Loredana Carobene; Nicola Bianchi; Annalisa Fui; Luigi Rizzi; Laura Bergantini; Giuseppe Cillis; Miriana d'Alessandro; Maria Antonietta Mazzei; Rosa Metella Refini; Piersante Sestini; Elena Bargagli; Paola Rottoli Journal: Respir Res Date: 2020-01-06